The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer

World Journal of Surgical Oncology

Volumn 5, Issue , 2007, Pages

  Duncan, Timothy J ^a   Watson, Nicholas F S ^a,b   Al Attar, Ahmad H ^a   Scholefield, John H ^b   Durrant, Lindy G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; MUCIN 1; MUCIN 3; TUMOR MARKER;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL ADHESION; CLINICAL TRIAL; COLON SURGERY; COLORECTAL CANCER; DATA BASE; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL; TISSUE MICROARRAY; UNIVARIATE ANALYSIS; ADJUVANT CHEMOTHERAPY; COLON RESECTION; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PATHOLOGY; PROBABILITY; PROSPECTIVE STUDY; REGISTER;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MUCIN-1; MUCIN-3; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33947533468     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-5-31     Document Type: Article

References (42)

1. Parkin DM Global cancer statistics in the year 2000 Lancet Oncol 2001 2 9 533-543 10.1016/S1470-2045(01)00486-7 11905707
2. Compton CC Colorectal carcinoma: Diagnostic, prognostic, and molecular features Mod Pathol 2003 16 4 376-388 10.1097/01.MP.0000062859.46942.93 12692203
3. Baldus SE Zirbes TK Engel S Hanisch FG Monig SP Lorenzen J Glossmann J Fromm S Thiele J Pichlmaier H Dienes HP Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas Int J Cancer 1998 79 2 133-138 10.1002/ (SICI)1097-0215(19980417)79:2<133::AID-IJC6>3.0.CO;2-U 9583726
4. Sakamoto H Yonezawa S Utsunomiya T Tanaka S Kim YS Sato E Mucin antigen expression in gastric carcinomas of young and old adults Hum Pathol 1997 28 9 1056-1065 10.1016/S0046-8177(97)90059-9 9308730
5. Utsunomiya T Yonezawa S Sakamoto H Kitamura H Hokita S Aiko T Tanaka S Irimura T Kim YS Sato E Expression of MUC1 and MUC2 mucins in gastric carcinomas: Its relationship with the prognosis of the patients Clin Cancer Res 1998 4 11 2605-2614 9829723
6. Baldus SE Monig SP Hanisch FG Zirbes TK Flucke U Oelert S Zilkens G Madejczik B Thiele J Schneider PM Holscher AH Dienes HP Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma Histopathology 2002 40 5 440-449 10.1046/j.1365-2559.2002.01389.x 12010364
7. Nakamori S Ota DM Cleary KR Shirotani K Irimura T MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma Gastroenterology 1994 106 2 353-361 7905449
8. You JF Hsieh LL Changchien CR Chen JS Chen JR Chiang JM Yeh CY Hsieh PS Fan CW Liu CT Tang R Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients Clin Cancer Res 2006 12 14 4244-4250 10.1158/ 1078-0432.CCR-06-0202 16857798
9. Baldus SE Monig SP Huxel S Landsberg S Hanisch FG Engelmann K Schneider PM Thiele J Holscher AH Dienes HP MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis Clin Cancer Res 2004 10 8 2790-2796 10.1158/1078-0432.CCR-03-0163 15102686
10. Chang SK Dohrman AF Basbaum CB Ho SB Tsuda T Toribara NW Gum JR Kim YS Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer Gastroenterology 1994 107 1 28-36 8020672
11. Park HU Kim JW Kim GE Bae HI Crawley SC Yang SC Gum JR Jr. Batra SK Rousseau K Swallow DM Sleisenger MH Kim YS Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia Pancreas 2003 26 3 e48-54 10.1097/ 00006676-200304000-00022 12657964
12. Rakha EA Boyce RW Abd El-Rehim D Kurien T Green AR Paish EC Robertson JF Ellis IO Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer Mod Pathol 2005 18 10 1295-1304 10.1038/modpathol.3800445 15976813
13. Wang RQ Fang DC Alterations of MUC1 and MUC3 expression in gastric carcinoma: Relevance to patient clinicopathological features J Clin Pathol 2003 56 5 378-384 10.1136/jcp.56.5.378 12719460
14. Leroy X Gouyer V Ballereau C Zerimech F Huet G Copin MC Aubert JP Porchet N Quantitative RT-PCR assay for MUC3 and VEGF mRNA in renal clear cell carcinoma: Relationship with nuclear grade and prognosis Urology 2003 62 4 771-775 10.1016/S0090-4295(03)00560-0 14550470
15. Weiss AA Babyatsky MW Ogata S Chen A Itzkowitz SH Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues J Histochem Cytochem 1996 44 10 1161-1166 8813081
16. Cao Y Blohm D Ghadimi BM Stosiek P Xing PX Karsten U Mucins (MUC1 and MUC3) of gastrointestinal and breast epithelia reveal different and heterogeneous tumor-associated aberrations in glycosylation J Histochem Cytochem 1997 45 11 1547-1557 9358856
17. Compton CC Fielding LP Burgart LJ Conley B Cooper HS Hamilton SR Hammond ME Henson DE Hutter RV Nagle RB Nielsen ML Sargent DJ Taylor CR Welton M Willett C Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 2000 124 7 979-994 10888773
18. Kononen J Bubendorf L Kallioniemi A Barlund M Schraml P Leighton S Torhorst J Mihatsch MJ Sauter G Kallioniemi OP Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 1998 4 7 844-847 10.1038/nm0798-844 9662379
19. Camp RL Charette LA Rimm DL Validation of tissue microarray technology in breast carcinoma Lab Invest 2000 80 12 1943-1949 11140706
20. Torhorst J Bucher C Kononen J Haas P Zuber M Kochli OR Mross F Dieterich H Moch H Mihatsch M Kallioniemi OP Sauter G Tissue microarrays for rapid linking of molecular changes to clinical endpoints Am J Pathol 2001 159 6 2249-2256 11733374
21. McShane LM Altman DG Sauerbrei W Taube SE Gion M Clark GM REporting recommendations for tumour MARKer prognostic studies (REMARK) Br J Cancer 2005 93 4 387-391 10.1038/sj.bjc.6602678 16106245
22. Watson NF Madjd Z Scrimegour D Spendlove I Ellis IO Scholefield JH Durrant LG Evidence that the p53 negative/Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: A tissue microarray study of 460 patients World J Surg Oncol 2005 3 47 1181828 16029489 10.1186/1477-7819-3-47
23. Watson NF Ramage JM Madjd Z Spendlove I Ellis IO Scholefield JH Durrant LG Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis Int J Cancer 2006 118 1 6-10 10.1002/ijc.21303 16003753
24. Watson NF Spendlove I Madjd Z McGilvray R Green AR Ellis IO Scholefield JH Durrant LG Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients Int J Cancer 2006 118 6 1445-1452 10.1002/ijc.21510 16184547
25. Kakar S Aksoy S Burgart LJ Smyrk TC Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival Mod Pathol 2004 17 6 696-700 10.1038/ modpathol.3800093 15017435
26. Quinn M BP Brock A, Kirby L, Jones J Cancer trends in England and Wales 1950-1999. London, The Stationary Office 2001
27. NICE Improving outcomes in colorectal cancers: Manual update. London, National Institute for Clinical Excellence 2004
28. Matsuda K Masaki T Watanabe T Kitayama J Nagawa H Muto T Ajioka Y Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma Jpn J Clin Oncol 2000 30 2 89-94 10.1093/jjco/ hyd023 10768872
29. Richter J Wagner U Kononen J Fijan A Bruderer J Schmid U Ackermann D Maurer R Alund G Knonagel H Rist M Wilber K Anabitarte M Hering F Hardmeier T Schonenberger A Flury R Jager P Fehr JL Schraml P Moch H Mihatsch MJ Gasser T Kallioniemi OP Sauter G High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer Am J Pathol 2000 157 3 787-794 10980118
30. Simon R Richter J Wagner U Fijan A Bruderer J Schmid U Ackermann D Maurer R Alund G Knonagel H Rist M Wilber K Anabitarte M Hering F Hardmeier T Schonenberger A Flury R Jager P Fehr JL Schraml P Moch H Mihatsch MJ Gasser T Sauter G High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer Cancer Res 2001 61 11 4514-4519 11389083
31. Hiraga Y Tanaka S Haruma K Yoshihara M Sumii K Kajiyama G Shimamoto F Kohno N Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer Oncology 1998 55 4 307-319 10.1159/000011868 9663420
32. Kimura T Tanaka S Haruma K Sumii K Kajiyama G Shimamoto F Kohno N Clinical significance of MUC1 and E-cadherin expression, cellular proliferation, and angiogenesis at the deepest invasive portion of colorectal cancer Int J Oncol 2000 16 1 55-64 10601549
33. Lugli A Zlobec I Baker K Minoo P Tornillo L Terracciano L Jass J Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status J Clin Pathol 2006
34. Manne U Weiss HL Grizzle WE Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas Clin Cancer Res 2000 6 10 4017-4025 11051251
35. Regimbald LH Pilarski LM Longenecker BM Reddish MA Zimmermann G Hugh JC The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer Cancer Res 1996 56 18 4244-4249 8797599
36. Ajioka Y Allison LJ Jass JR Significance of MUC1 and MUC2 mucin expression in colorectal cancer J Clin Pathol 1996 49 7 560-564 500570 8813954
37. Kemperman H Wijnands Y Wesseling J Niessen CM Sonnenberg A Roos E The mucin epiglycanin on TA3/Ha carcinoma cells prevents alpha 6 beta 4-mediated adhesion to laminin and kalinin and E-cadherin-mediated cell-cell interaction J Cell Biol 1994 127 6 Pt 2 2071-2080 10.1083/ jcb.127.6.2071 7528749
38. Wesseling J van der Valk SW Vos HL Sonnenberg A Hilkens J Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components J Cell Biol 1995 129 1 255-265 10.1083/ jcb.129.1.255 7698991
39. Brabletz T Herrmann K Jung A Faller G Kirchner T Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas Am J Pathol 2000 156 3 865-870 10702403
40. Wen Y Caffrey TC Wheelock MJ Johnson KR Hollingsworth MA Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin J Biol Chem 2003 278 39 38029-38039 10.1074/jbc.M304333200 12832415
41. Nguyen PL Niehans GA Cherwitz DL Kim YS Ho SB Membrane-bound (MUC1) and secretory (MUC2, MUC3, and MUC4) mucin gene expression in human lung cancer Tumour Biol 1996 17 3 176-192 8638091
42. Copin MC Buisine MP Leteurtre E Marquette CH Porte H Aubert JP Gosselin B Porchet N Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas Hum Pathol 2001 32 3 274-281 10.1053/hupa.2001.22752 11274635